Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Completed · Phase 3 · Has a placebo group

Conditions studied: Submental Fat, Healthy

In brief

The investigation of the long-term safety and maintenance of efficacy of ATX-101 in reduction of submental fat.

Key facts

Study ID
NCT02163902
Run by
Kythera Biopharmaceuticals
People needed
224
Starts
2013-12-01
Expected to finish
2016-08-01
Last updated by the study team
2020-02-17

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.